Last update 23 Jan 2025

Trivalent influenza virus split vaccine (MDCK cells)(Chengdu Olymvax)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Multivalent vaccine
Synonyms-
Target-
Mechanism
Immunostimulants
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
Influenza, Human
Inactive Indication-
Originator Organization
Chengdu Olymvax Biopharmaceuticals, Inc.Chengdu Olymvax Biopharmaceuticals, Inc.
Active Organization
Chengdu Olymvax Biopharmaceuticals, Inc.Chengdu Olymvax Biopharmaceuticals, Inc.Lanzhou Bailing Biotechnology Co., Ltd.Lanzhou Bailing Biotechnology Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Trivalent influenza virus split vaccine (MDCK cells)(Chengdu Olymvax)
CTR20250309
/ Not yet recruitingPhase 1
评价三价流感病毒裂解疫苗（MDCK细胞）在6月龄及以上人群中接种的安全性和初步免疫原性的随机、盲法、阳性对照Ⅰ期临床试验
[Translation] A randomized, blinded, positive-controlled phase I clinical trial to evaluate the safety and preliminary immunogenicity of a trivalent influenza virus split vaccine (MDCK cells) in people aged 6 months and above
100 Clinical Results associated with Trivalent influenza virus split vaccine (MDCK cells)(Chengdu Olymvax)
Login to view more data
100 Translational Medicine associated with Trivalent influenza virus split vaccine (MDCK cells)(Chengdu Olymvax)
Login to view more data
100 Patents (Medical) associated with Trivalent influenza virus split vaccine (MDCK cells)(Chengdu Olymvax)
Login to view more data
100 Deals associated with Trivalent influenza virus split vaccine (MDCK cells)(Chengdu Olymvax)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Influenza, HumanPhase 1
CN
Chengdu Olymvax Biopharmaceuticals, Inc.Chengdu Olymvax Biopharmaceuticals, Inc.
23 Jan 2025
Influenza, HumanPhase 1
CN
Lanzhou Bailing Biotechnology Co., Ltd.Lanzhou Bailing Biotechnology Co., Ltd.
23 Jan 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free